Anti-Diabetogenic Properties of Mineralocorticoid Receptor Antagonists: Implications for Enhanced Safety and Efficacy of Post-Transplantation Pharmacotherapies.
Ming, Yingzi
Anti-Diabetogenic Properties of Mineralocorticoid Receptor Antagonists: Implications for Enhanced Safety and Efficacy of Post-Transplantation Pharmacotherapies. [electronic resource] - Medical science monitor : international medical journal of experimental and clinical research Feb 2019 - 1102-1104 p. digital
Publication Type: Editorial
1643-3750
10.12659/MSM.914340 doi
Calcineurin--metabolism
Calcineurin Inhibitors
Cyclosporine
Diabetes Complications--drug therapy
Diabetes Mellitus--chemically induced
Everolimus
Graft Rejection--drug therapy
Humans
Immunosuppressive Agents--metabolism
Kidney Transplantation
Mineralocorticoid Receptor Antagonists--pharmacology
Sirolimus
Spironolactone--pharmacology
Tacrolimus
Transplantation Tolerance--physiology
Anti-Diabetogenic Properties of Mineralocorticoid Receptor Antagonists: Implications for Enhanced Safety and Efficacy of Post-Transplantation Pharmacotherapies. [electronic resource] - Medical science monitor : international medical journal of experimental and clinical research Feb 2019 - 1102-1104 p. digital
Publication Type: Editorial
1643-3750
10.12659/MSM.914340 doi
Calcineurin--metabolism
Calcineurin Inhibitors
Cyclosporine
Diabetes Complications--drug therapy
Diabetes Mellitus--chemically induced
Everolimus
Graft Rejection--drug therapy
Humans
Immunosuppressive Agents--metabolism
Kidney Transplantation
Mineralocorticoid Receptor Antagonists--pharmacology
Sirolimus
Spironolactone--pharmacology
Tacrolimus
Transplantation Tolerance--physiology